The tumourigenicity of iPS cells and their differentiated derivates

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 6, 2013, Pages 782-791

  Liu, Zhiqiang ^a   Tang, Yu ^b   Lü, Shuanghong ^a   Zhou, Jin ^a   Du, Zhiyan ^a   Duan, Cuimi ^a   Li, Zhiyan ^b   Wang, Changyong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

Bioluminescence imaging; Induced cardiac differentiation; Induced pluripotent stem cells; Tumourigenicity

Indexed keywords

BIOLOGICAL MARKER; FIREFLY LUCIFERASE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION; CYTOLOGY; GRAFT SURVIVAL; HEART MUSCLE CELL; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PLURIPOTENT STEM CELL; REPORTER GENE; SUBCUTANEOUS DRUG ADMINISTRATION; TERATOMA; TRANSPLANTATION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; GENES, REPORTER; GRAFT SURVIVAL; INDUCED PLURIPOTENT STEM CELLS; INJECTIONS, SUBCUTANEOUS; LUCIFERASES, FIREFLY; MICE; MICE, NUDE; MYOCYTES, CARDIAC; TERATOMA;

IPS; MURINAE; MUS; MUS MUSCULUS;

EID: 84879498019     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12062     Document Type: Article

References (33)

1. Asgari S, Pournasr B, Salekdeh GH, et al. Induced pluripotent stem cells: a new era for hepatology. J Hepatol. 2010; 53: 738-51.
2. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell. 2008; 134: 877-86.
3. Patel M, Yang S. Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 2010; 6: 367-80.
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76.
5. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with parkinson's disease. Proc Natl Acad Sci USA. 2008; 105: 5856-61.
6. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with ips cells generated from autologous skin. Science. 2007; 318: 1920-3.
7. Nelson TJ, Martinez-Fernandez A, Yamada S, et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009; 120: 408-16.
8. Dai B, Huang W, Xu M, et al. Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. J Am Coll Cardiol. 2011; 58: 2118-27.
9. Carpenter L, Carr C, Yang CT, et al. Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev. 2012; 21: 977-86.
10. Zhang Y, Wang D, Chen M, et al. Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS ONE. 2011; 6: e19012.
11. Ahmed RP, Ashraf M, Buccini S, et al. Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med. 2011; 6: 171-8.
12. Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells. 2010; 28: 1568-70.
13. Templin C, Zweigerdt R, Schwanke K, et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation. 2012; 126: 430-9.
14. Mauritz C, Martens A, Rojas SV, et al. Induced pluripotent stem cell (ipsc)-derived flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J. 2011; 32: 2634-41.
15. Huang J, Chen T, Liu X, et al. More synergetic cooperation of yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Cell Res. 2009; 19: 1127-38.
16. Liu Z, Wang H, Wang Y, et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 2012; 33: 3093-106.
17. Caspi O, Huber I, Kehat I, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007; 50: 1884-93.
18. Cao F, van der Bogt KE, Sadrzadeh A, et al. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev. 2007; 16: 883-91.
19. Ye L, Swingen C, Zhang J. Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr Cardiol Rev. 2013; 9: 63-72.
20. Teoh HK, Cheong SK. Induced pluripotent stem cells in research and therapy. Malays J Pathol. 2012; 34: 1-13.
21. Yamashita T, Kawai H, Tian F, et al. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant. 2011; 20: 883-91.
22. Ramirez MA, Pericuesta E, Fernandez-Gonzalez R, et al. Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies. Int J Dev Biol. 2007; 51: 397-407.
23. Fu W, Wang SJ, Zhou GD, et al. Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo. Stem Cells Dev. 2012; 21: 521-9.
24. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation. 2006; 113: 1005-14.
25. Swijnenburg RJ, Schrepfer S, Cao F, et al. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev. 2008; 17: 1023-9.
26. Kutschka I, Chen IY, Kofidis T, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation. 2006; 114: I167-73.
27. Klug MG, Soonpaa MH, Koh GY, et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest. 1996; 98: 216-24.
28. Kolossov E, Bostani T, Roell W, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006; 203: 2315-27.
29. Hattori F, Chen H, Yamashita H, et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods. 2010; 7: 61-6.
30. Uosaki H, Fukushima H, Takeuchi A, et al. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by vcam1 surface expression. PLoS ONE. 2011; 6: e23657.
31. Lin Q, Fu Q, Zhang Y, et al. Tumourigenesis in the infarcted rat heart is eliminated through differentiation and enrichment of the transplanted embryonic stem cells. Eur J Heart Fail. 2010; 12: 1179-85.
32. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009; 4: 381-4.
33. Li Z, Yang CS, Nakashima K, et al. Small RNA-mediated regulation of ips cell generation. EMBO J. 2011; 30: 823-34.